RxDoctor Payments Data

Arthur Braunwell, DO

Family Medicine · Ship Bottom, NJNPI 1821094640

Payments from drug & device makers

$840in general payments, 2019–2025

Across 55 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$309
  • GSK$99
  • AstraZeneca$84
  • Pfizer$83
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$42
  • Exact Sciences$34
  • plus $190 from 9 others

What the payments were for

  • Food & beverage$840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$840 in reported general payments places this provider in the 60th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$145,559
Medicare patients
1,053
Services billed
1,992

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$38,788
EliquisApixaban25$30,848
JanuviaSitagliptin Phosphate22$28,902
JardianceEmpagliflozin22$20,369
FarxigaDapagliflozin Propanediol19$19,228
JanumetSitagliptin Phos/Metformin Hcl19$17,459
Albuterol Sulfate HfaAlbuterol Sulfate254$5,103
CefuroximeCefuroxime Axetil382$4,613
Atorvastatin Calcium164$2,233
Methylprednisolone287$1,827
Rosuvastatin Calcium84$1,645
Lisinopril134$1,382
FenofibrateFenofibrate Nanocrystallized15$1,346
Losartan Potassium75$1,257
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$27$46,36241 claims
Novo NordiskOzempic$309$38,78832 claims
PfizerEliquis$83$30,84825 claims
Boehringer IngelheimJardiance$29$20,36922 claims
AstraZenecaFarxiga$84$19,22819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Ship Bottom

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →